DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Ohman EM, Roe MT, Steg PG. et al.
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Lancet 2017;
389: 1799-1808
We do not assume any responsibility for the contents of the web pages of other providers.